# Menthol In Neuropathy Trial

> **NCT04276727** · PHASE2 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 52 (actual)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DRUG:** MINT study IMP

## Key facts

- **NCT ID:** NCT04276727
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-04
- **Primary completion:** 2022-03-24
- **Final completion:** 2022-03-24
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04276727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04276727, "Menthol In Neuropathy Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04276727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*